ReviewBlood cancer journal2019
Myelofibrosis in 2019: moving beyond JAK2 inhibition.
Michael Schieber et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
49 papers cite it
this paperpooled ittrialcites it
ReviewBlood cancer journal2019
Michael Schieber et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.